Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Cutaneous symptoms in drug allergy: what have we learnt?

Mayorga, Cristobalina; Torres, Maria Jose; Fernandez, Javier; Canto, Gabriela; Blanca, Miguel

Current Opinion in Allergy and Clinical Immunology: October 2009 - Volume 9 - Issue 5 - p 431–436
doi: 10.1097/ACI.0b013e3283307abc
Skin allergy: Edited by Torsten Zuberbier and Thomas Werfel
Buy

Purpose of review A number of studies over recent years have shown the relevance of nonimmediate immunological reactions to drugs and emphasized the need for these reactions to be studied in greater depth, including both in-vivo and in-vitro tests and provocation studies.

Recent findings Several clinical entities are involved, ranging from mild to severe reactions. Nonimmediate reactions have a special tropism for the skin, although other organ-specific or systemic reactions may also occur. In the affected organ, the drug acts as a hapten or protohapten, originating an immunological stimulus that is followed by recruitment of T lymphocytes and other types of cells, depending on the reaction. This involves a trafficking phenomenon in which these cells use different receptors that interplay with their corresponding ligands in the tissue. In addition, a number of activation and cytotoxic markers are also expressed, which are related with disease severity.

Summary Current studies provide overwhelming evidence of the interaction between the organ involved, very often the skin, and immunocompetent cells. This is of relevance for diagnostic and therapeutic approaches.

aResearch Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Spain

bAllergy Service, Carlos Haya Hospital, Málaga, Spain

cAllergy Service, Elche Hospital, Alicante, Spain

dAllergy Unit, Infanta Leonor Hospital, Madrid, Spain

Correspondence to Miguel Blanca, Allergy Service, Carlos Haya Hospital, Pl. Hospital Civil, 29009 Malaga, Spain Tel: +34 951290190; fax: +34 951290302; e-mail: mblancag@gmail.com

Copyright © 2009 Wolters Kluwer Health, Inc. All rights reserved.